Oral Iron Repletion Effects On Oxygen Uptake in Heart Failure

PHASE3CompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

September 3, 2014

Primary Completion Date

April 6, 2016

Study Completion Date

April 6, 2016

Conditions
Chronic Heart Failure
Interventions
DRUG

Polysaccharide Iron Complex 150 mg

Oral Iron

DRUG

Placebo (for Polysaccharide Iron Complex)

Sugar capsule designed to mimic Polysaccharide Iron Complex.

Trial Locations (17)

17603

Lancaster General Hospital, Lancaster

19104

Hospital of the University of Pennsylvania, Philadelphia

19107

Thomas Jefferson University, Philadelphia

21287

Johns Hopkins Hospital, Baltimore

27705

Duke University Medical Center, Durham

30322

Emory University School of Medicine, Atlanta

44106

University Hospitals-Case Medical Center, Cleveland

44109

Metor Health System, Cleveland

44195

Cleveland Clinic Foundation, Cleveland

55905

Mayo Clinic, Rochester

63110

Saint Louis University Hospital, St Louis

Washington University School of Medicine, St Louis

84107

University of Utah Hospitals and Clinics, Murray

02111

Tufts Medical Center, Boston

02114

Massachusetts General Hospital, Boston

02115

Brigham and Women's Hospital, Boston

05401

The University of Vermont - Fletcher Allen Health Care, Burlington

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Adrian Hernandez

OTHER

NCT02188784 - Oral Iron Repletion Effects On Oxygen Uptake in Heart Failure | Biotech Hunter | Biotech Hunter